Physical activity and sleep disorders are established risk factors for many diseases, but their etiology is poorly understood, partly due to a reliance on self-reported evidence. Here we 2 report a genome-wide association study (GWAS) of wearable-defined and machine-learned physical activity and sleep phenotypes in 91,112 UK Biobank participants, and self-reported physical activity in 351,154 UK Biobank participants. While the self-reported activity analysis resulted in no significant (p<5x10 -9 ) loci, the analysis of objectively-measured traits identified 10 loci, 6 of which are novel. These 10 loci account for 0.05% of activity and 0.33% of sleep phenotype variation, but genome-wide estimates suggest that common variation accounts for ~12% of phenotypic variation, indicating high polygenicity. Heritability was higher in women than in men for overall activity (Δh 2 = 4%, p=6.3x10 -5 ), moderate intensity activity (6%, p=6.7x10 -8 ), and walking (5%, p=2.6x10 -6 ). Heritability partitioning, enrichment and pathway analyses all indicate the central nervous system plays a role in activity behaviours.
INTRODUCTION
Physical inactivity is a global public health threat and is estimated to cost health-care systems ~$50 billion per year worldwide 1, 2 . It is associated with a range of common diseases including multiple cardiometabolic outcomes such as obesity, type 2 diabetes, and cardiovascular diseases 3 . Alterations in sleep duration also associate with negative health outcomes, including cardio-metabolic diseases 4 and psychiatric disorders 5 . In response to physical activity and sleep sharing a movement continuum, recent Canadian public health guidelines now recommend how youth should spend time in a variety of movement-related behaviours that make up the whole day 6 .
Twin and family studies have shown that self-reported daily physical activity is heritable, but with a large degree of heterogeneity in measurement methods and sample size (h 2 range: 0%-78%) 7 . Emerging evidence shows a genetic contribution to physical activity, finding three variants 8 associated with standard UK Biobank activity metrics 9 . Recent GWAS have also reported common variants that are associated with sleep duration [10] [11] [12] . However, GWAS of behavioural traits such as physical activity and sleep have mostly relied on self-reported data that are prone to measurement error and thus have limited statistical power. It is also possible that self-reported measures capture how well individuals perceive what they do, rather than what they actually do. Consequently, our understanding of the genes and biological pathways that underpin physical activity and sleep behaviours is still limited.
To better understand the genetic underpinnings of these behavioural traits, we performed a GWAS in 91,112 UK Biobank participants who were asked to wear activity trackers over a seven-day period. We used statistical machine learning to derive objective measures of physical activity and sleep from raw device data, which helped identify novel associations to genetic loci. The associated loci reveal pathways in the central nervous system that help advance our understanding of biological processes underlying human sleep and activity behaviours. Our study also reveals the importance of having objective measures at scale to detect genetic effects for behavioural traits. Mendelian randomization supports a role for physical activity in the reduction of body fat percentage and systolic blood pressure.
(Methods).
Additionally, we applied a machine-learning model, using balanced random forests with Markov confusion matrices 14 , to identify which one of seven activity states an individual was in at any given time. We trained and evaluated the model in 57 free-living individuals to distinguish between activity states, with an overall classification score of kappa=0.79 in correctly predicting what activity state an individual is in for any given 30-second time period (Table S1 ). This is comparable to the level of performance (kappa=0.80) that we expect from humans defining reference activity labels in free-living evaluation datasets. We then decided to concentrate on sleep duration, sitting or standing, and walking behaviours as these occurred most commonly and are of most public health interest. We applied this model to over 100,000 UK Biobank participants 14 ( Fig S1) .
Novel loci associated with objective measures of physical activity, but not self-report
After quality control, 91,112 participants of European descent and 14,666,529 SNPs remained for subsequent genetic association analysis (Methods). Using similar quality control criteria, we also extracted information on self-reported physical activity (via the international physical activity questionnaire short-form 15 ) for 351,154 UK Biobank participants of European descent (Methods). To maximise statistical power, we performed our analyses in BOLT-LMM 16 , which applies a linear mixed model to the data, allowing for inclusion of related individuals and those of varying genetic ancestry 17 . We additionally included assessment centre, genotyping array, age, and age squared as covariates.
Our analysis identified 10 significant loci (p<5x10 -9 ) that were separated by at least 400 kilobases (kb) (Table1, Fig S1) . We empirically derived this threshold (p<5x10 -9 ) for genome-wide significance that considers multiple testing in densely imputed data 18 . Six loci were novel and these include: one for overall activity (rs59499656 near SYT4, p=2. (Table S2) . Of note, no loci were associated with self-reported physical activity status in our analysis (Fig 1) .
Nominal replication was seen for loci previously reported for overall and moderate intensity activity 8 (near DNAJB4 and PML), sleep 12 (near EBLN3P, PRKCB, and RPGRIP1L), and sitting (near LY6H) ( Table S3) . No other findings were confirmed from previous GWAS that relied on self-report measures of physical activity and sleep (Table S3) .
Genomic control lambda across the GWAS ranged from 1.1 -1.25, indicating modest deviation in the test statistics compared with the expectation. Estimation of the LD Score intercepts, using LD score regression 24 , revealed intercepts near 1.00 (range: 0.993 -1.015), indicating that the genomic inflation was due to a polygenic architecture rather than inflation due to uncorrected population structure. We performed approximate conditional analysis in each locus reaching genome-wide significance using Genome-wide Complex Trait Analysis 25 (GCTA) but did not identify secondary signals in any locus. Gene-based to the phenotypic variance explained. For example, explained phenotypic variance ranged from 11.8% for walking to 13.2% for sleep when we selected independent SNPs (r 2 <0.1) with p<5x10 -3 and distance >250kb from index SNPs.
We applied partitioned heritability 27 analysis for tissue and functional categories using LDscore regression 24 . After taking the median value across all the 5 accelerometer-measured traits, we identified significant enrichments in the central nervous system and adrenal/pancreatic tissues (p<5x10 -3 , accounting for 10 cell types) (Fig 2, S4) 
Sexual dimorphism in physical activity and sleep
Given that known sex differences exist for physical activity levels 9 and muscle and fat mass distribution 29 , we investigated genetic sexual dimorphisms in our activity traits. Genetic correlations 30 of trait architectures as measured using LD score regression 24 showed strong correlation between men and women; correlations ranged from 0.89 for moderate activity to 0.96 for overall activity (Fig S5) . In addition, there was no evidence of sexual dimorphism using strict criteria for heterogeneity of effects between men and women (p<5x10 -9 ).
Heritability in women was higher than that in men for overall activity (Δh 2 = 4%, p=6.3x10 -5 ), moderate intensity activity (6%, p=6.7x10 -8 ), and walking (5%, p=2.6x10 -6 ) (Fig S5) . We found no evidence for sexually-dimorphic heritability in sleep (p=0.12) and sit/stand behaviours (p=0.27). We found some evidence of sexually dimorphic variance explained in 4 of the 5 traits (Fig S5) .
Physical activity and sleep, and their relationship with other traits
While physical activity and sleep are established risk factors for multiple diseases from observational epidemiology, the extent to which their underlying genetic architectures are shared with disease phenotypes is unknown 7 . We conducted various analyses that included:
1) genome-wide genetic correlations between our traits and those from publicly-available GWAS data using LD score regression 24 Fig   S6) . Associations with anthropometric and cognitive health traits were particularly common (Note S1). In general, increases in overall activity and walking phenotypes were genetically correlated with improved health status, while increases in sleep duration were negatively correlated with fluid intelligence scores and health status. Increases in sitting/standing time were genetically correlated with increased fluid intelligence scores, but decreased health status (Note S1, Table S6 ).
To investigate whether activity and sleep might contribute causally to disease outcomes, we performed Mendelian randomization (MR) analysis in 278,367 UK Biobank participants who were not included in our discovery analysis, and other publicly available GWAS summary data from the MR-Base web platform 34, 35 (Methods) . Rather than selecting all significant traits from the previous genetic correlation analyses, we decided to only focus on major diseases and risk factors. These included cardiovascular disease (CHD, stroke, heart failure), type 2 diabetes, Alzheimer's, major cancer subtypes, blood pressure, and anthropometric traits (BMI and body fat %). For the MR analysis of each trait, we selected instrument variables using traditional criteria for genome wide significance (p<5x10 -8 ) and then followed a number of steps to denote potential causality with disease outcomes (Methods, Note S2). These included: maximum likelihood estimates 36 , leave-one-out analyses, robustness against pleiotropy via median and mode estimators, MR-Egger, and bidirectional tests 37 . We found consistent evidence of inverse relationships for overall activity with body fat percentage (beta per SD higher overall activity: -0.44, SE=0.047, p=2.70x10 -21 ) and systolic blood pressure (beta per SD: -0.71, SE=0.125, p=1.38x10 -8 ) ( Tables S9-11) .
While there was evidence of bi-directional relationships (which is plausible), directionality analyses found evidence in support of activity being proximal to body fat percentage and systolic blood pressures (Tables S11-12) .
Potential functional and biological mechanisms for physical activity and sleep
We anticipated the use of objective measures would not only identify activity and sleep associated variants, but also provide insight on potential functional and biological mechanisms for these traits. First, we used DEPICT 38 (Fig 3, S7) . We also identified pathways enriched in neurological disease, brain structure, and cognitive function, among other traits (Fig S8) .
DISCUSSION
Our analysis of 91,112 individuals identified 10 loci significantly associated with objectively measured physical activity and sleep traits. While these loci alone account for less than 0.5% of the variation in physical activity, our analyses suggest that as much as 12% of activity variation might be accounted for by common (minor allele frequency > 1%) genetic variation. We found heritability was higher in women than in men for activity traits, but no differences were found for sleep and sitting/standing. As anticipated, physical activity and sleep have polygenic architectures and share biology with multiple traits including intelligence, education, obesity, and cardiometabolic diseases.
Our results advocate the value of physical activity for the reduction of adiposity and blood pressure. Until now, it has been difficult to discern whether associations between activity and disease are truly causal or biased due to reverse causality, confounding, and self-report measurement error associated with traditional observational studies 39 . Ascertainment bias is also an issue in randomised controlled trials of physical activity, due to difficulties in blinding participants to behavioral interventions 40 . Debate on whether obesity is a determinant of physical activity, or vice-versa, has previously lacked information due to a paucity of instrument variables for physical activity 7, 41 . Our MR analyses suggest that higher levels of physical activity might causally lower body fat percentage and systolic blood pressure. We note that our current MR estimates are based on a limited number of SNPs. While this number of markers may be insufficient to comprehensively instrument a complex phenotype, early studies of body mass index used only one SNP and obtained reliable estimates 42 .
We observed an important role for the central nervous system with respect to physical activity and sleep, consistent with emerging literature 8 . In addition to these findings from heritability partitioning, enrichment and pathway analyses; our gene-set and pheWAS analyses showed genetic overlap with neurodegenerative diseases, mental health wellbeing, brain structure, function, and connectivity. Intriguingly, a recent GWAS of BMI highlighted a key role for neurological pathways in overall fat distribution 43 while a GWAS of fat distribution as measured by waist-to-hip ratio highlight adipose pathways 44 . It is therefore possible that our findings might be driven through obesity, as we observed strong genetic correlations between activity and obesity traits. However, as this is one of the first large-scale physical activity genetic studies, we have likely only begun to understand the complex interplay between activity, cardiometabolic phenotypes, and neurologic health.
Our work demonstrates the importance of large-scale objective measures to identify genetic associations with behavioural phenotypes. For example, we found no loci were associated with self-reported activity despite the much larger sample of 351,154 UK Biobank participants. Our heritability estimates for sleep were consistent with previous self-reported literature 19-21 , but we found that self-reported data significantly underestimated heritability for physical activity 8 (~20% vs ~5%). While large-scale self-reported measures have appeared robust for other phenotypes such as birthweight 45 and major depression status 46 , it appears that measurement error is a considerable obstacle when assessing behavioural traits.
Recall, comprehension, and social-desirability bias are more prevalent in behavioural traits such as physical activity, where phenotypic agreement is generally poor between subjective and objective measures (typically r<0.2) 47 .
This study has many strengths including: objectively measured behavioural phenotypes validated in free-living environments, use of linear mixed models, and large sample sizes, all key to maximise power in genetic discovery analyses; and Mendelian Randomization analyses, for delineating causal relationships. However, given the cohort age range years) and inclusion of European ancestry individuals only, we cannot necessarily assume our results generalise to other age groups or ancestral populations. Larger studies of common genetic variation, and studies in non-European populations, will help in replicating these findings, as well as continue to further refine the biology of physical activity and the diseases it might cause. To account for the likely U-shape relationship between sleep and disease outcomes 48 , rather than a linear relationship as assumed in current models, future work will be also required for MR sleep analysis.
In summary, we conducted the largest GWAS of wearable-defined and machine-learned sleep and physical activity phenotypes to date, and identified 10 trait-associated loci. Our analysis shows shared genetic pathways with multiple traits including intelligence-related phenotypes and cardiometabolic disease. In support of national and international clinical guidance, this study provides strong evidence for physical activity in the prevention of adiposity and blood pressure. Participants were asked to wear a wrist-worn accelerometer (same as in UK Biobank) for a 24-hour period and then given a £20 voucher for taking part in this study that received ethical approval from University of Oxford (Inter-Divisional Research Ethics Committee (IDREC) reference number: SSD/CUREC1A/13-262).
METHODS

Participants
Device
Participants wore an Axivity AX3 wrist-worn triaxial accelerometer on their dominant hand at all times over a seven-day period. It was set to capture tri-axial acceleration data at 100Hz
with a dynamic range of +-8g. This device has demonstrated equivalent output 49 to the GENEActiv accelerometer which has been validated using both standard laboratory and free-living energy expenditure assessment methods 50, 51 . For data pre-processing we followed procedures that we developed as part of the UK Biobank accelerometer data processing expert group 9 , that included device calibration, resampling to 100Hz, and removal of noise and gravity.
Development and validation of machine-learned phenotypes
To create a "ground truth" to extract sleep, sitting/standing, and walking time from sensor data, participants in the validation study also wore cameras in natural free-living, rather than constrained laboratory, environments. 14 . For activity classification we used random forests 55 which offer a powerful nonparametric discriminative method for classification that offers state-of-the-art performance 56 . Random forests are able to classify data points, but do not have an understanding of our data as having come from a time series. Therefore we then used a hidden Markov model 57 (HMM) to smooth our predictions. This smoothing corrects erroneous predictions from the random forest, such as where the error is a blip of one activity surrounded by another and the transitions between those two classes of activity are rare. This allowed us to train a model using all free-living ground truth data, achieving 86% accuracy across classes of interest 14 (Table S1 ).
Sleep and physical activity phenotypes in UK Biobank
To predict sleep, sitting/standing, and walking, we applied our machine learning method to predict behaviour for each 30-second epoch in 103,712 UK Biobank participants' accelerometer data. For any given time window (e.g., one hour, one day, etc.) the probability of a participant engaging in a specific behaviour type was expressed as the number-ofepoch-predictions-for-class divided by the number-of-epochs. For overall activity levels, we selected average vector magnitude for each 30-second epoch, which is the recommended variable for activity analysis 9 . This variable has been shown to account for 44-47% explained variance versus combined sensing heart-rate + trunk-acceleration (a proxy for free-living physical activity energy expenditure) in 1695 UK adults 51 . To infer time spent in moderate intensity activity, we considered all epoch periods at or greater than 100 milli-gravity units.
This threshold has been shown to be equivalent to 3 METs in laboratory experiments 58 .
Device non-wear time was automatically identified as consecutive stationary episodes lasting for at least 60 minutes 9 . These non-wear segments of data were imputed with the average of similar time-of-day data points, for each behaviour prediction, from different days of the measurement. We excluded participants whose data could not be calibrated (n=0), had too many clipped values (n=3), had unrealistically high values (average vector magnitude > 100mg) (n=32), or who had poor wear-time (n=6,860). We defined minimum wear time criteria as having at least three days (72 hours) of data and also data in each onehour period of the 24-hour cycle 9 .
We also extracted information on self-reported physical activity (via the international physical questionnaire short-form 15 ). Here, self-reported walking (field #874), moderate (#894), and vigorous (#914) activity duration were converted into MET-hours (a unit of physical activity energy expenditure) following procedures described elsewhere 15 . Rather than ignoring participants at the bottom end of the self-reported activity spectrum 8 , we included such participants who answered '0' to number of days in a week that they walked (field #864) or did moderate (#field 884) or vigorous (field #904) intensity activity (for at least 10 minutes).
Participants were removed from analysis if they answered "Do not know" or "prefer not to answer" to the aforementioned questions (n=117,055).
Genotyping and quality control
The UK Biobank provides ~92 million variants, including imputation based on UK10K 
Identification of loci associated with activity and sleep traits.
To improve our power to detect associations, we used BOLT-LMM 16 to perform linear mixed models analysis. As this adjusts for population structure and relatedness, we could include many additional individuals (13,320 for accelerometer analysis and ~70,000 for self-report analysis) than if following the common practice of analysing a reduced set of unrelated white British individuals using linear regression 60 . We included assessment centre, genotyping array, age, and age squared as covariates. Sensitivity analysis showed we did not need to include principal components of ancestry as covariates in our linear mixed models. We then used PLINK 61 (version 1.9) to exclude candidate variants (p<1x10 -5 ) that deviated from
Hardy-Weinberg equilibrium (p<1x10 -7 ). To identify genome-wide-significant (GWS) loci, we defined a distance criterion of +-400kb surrounding each GWS peak (P<5x10 -9 ). We empirically derived this threshold for genome-wide significance that considers multiple testing and densely imputed data 18 . For reporting, we also identified loci using a traditional genome-wide significance. To identify novel loci, we looked for genes more than 400kb away from loci identified in the above SNP association analysis.
Genetic architecture of activity and sleep traits
To estimate heritability of each trait, we used BOLT-LMM 16 for computational efficiency, after sensitivity analysis showed negligible differences in estimates between BOLT-LMM and restricted maximum likelihood analysis 66 implemented in BOLT-REML. We applied partitioned heritability 27 analysis across the phenotypes by tissue and functional category using LD-score regression 24 with the LDSC tool. Significant enrichments for individual traits were identified using thresholds of p<1x10 -3 for tissues (i.e. p<0.05/10 cell types/5 traits) and p<3.57x10 -4 for functional categories (i.e. p<0.05/28 categories/5 traits). We also investigated enrichments in the median value across all accelerometer-measured traits.
To calculate the explained phenotypic variance for each trait, we used the PRSice 67 tool to generate polygenic risk scores for the lead SNP in GWS loci and also for all SNPs with p<5x10 -3 , distance > 250kb from index SNPs, and r 2 < 0.1. The same participant inclusion criteria were used as for association analysis.
To identify plausible causal SNPs associated with sleep and activity phenotypes, we used the FINEMAP 28 software. Configurations of plausible causal SNPs from a 1Mb window around each genome-wide significant locus were calculated on the assumption that there were a maximum of five causal variants per locus. Across all loci, we defined plausible causal SNPs as those meeting a log 10 Bayes Factor > 2.
Sexual dimorphism in activity and sleep traits
To investigate potential sources of sex heterogeneity, we ran the aforementioned genome wide association analyses for men and women independently. Genetic correlations 30 of trait architectures between men and women were measured using LD score regression 24 for
each phenotype. We also tested for heterogeneity of effect estimates 29 between men and women for all SNPs using the EasyStrata 68 tool, with P<5x10 -9 to assess significance.
Heritability differences between men and women for each trait were assessed by extracting a two-tailed p-value from the following z-score (where 'var' indicates variance):
To estimate genetic contributions to phenotypic variance for men and women separately, we selected index SNPs from loci with a less stringent p<5x10 -7 , due to smaller sample sizes within strata.
Associations of activity and sleep traits with other traits
To estimate genetic correlations between our movement phenotypes and other complex traits and diseases, we used LD score regression 24 implemented in the LD-Hub web resource 31 . We did not test moderate intensity activity as it had a strong genetic correlation with overall activity (r g = 0.97, se = 0.004, Fig S9) . To assess significance, we corrected for 3,328 tests (activity/sleep/sitting/walking x 832 phenotypes available on LD-Hub) with p<1.5x10 -5 .
To examine whether the genome-wide significant SNPs identified in our analysis affected other traits, we used the Oxford Brain Imaging Genetics Server (big.stats.ox.ac.uk 32 ) to perform a phenome-wide association study (PheWAS) on almost 4,000 traits in UK Biobank participants. This included GWAS results of ~2,000 phenotypes in ~330,000 UK Biobank participants published by the Neale lab at the Broad Institute, and the remaining traits were brain imaging-derived phenotypes measured on a subset of ~10,000 UK Biobank participants 32 . To assess significance, we corrected for 40,000 tests (10 loci x 4,000 traits) with p<1.25x10 -6 . Additionally, we extracted previously reported GWAS associations within 400kb and r 2 >0.2 of accelerometer index SNPs from the NHGRI GWAS catalog 33 .
To investigate whether activity and sleep might causally contribute to disease outcomes, we performed Mendelian Randomization (MR) analysis. Rather than selecting all significant traits identified in other correlation analysis, we decided to concentrate on major diseases and peripheral risk factors. These included vascular disease (CHD, stroke, heart failure), diabetes, Alzheimer's, major cancer subtypes, blood pressure, and anthropometric traits (BMI and body fat %). Disease phenotypes were prepared following similar procedures as used for UK Biobank variables in the LD-Hub web resource 31 . We defined hypertensive cases as individuals with systolic blood pressure of >140 mmHg, or a diastolic blood pressure of >90 mmHg, or the report of blood pressure medication usage. For the analysis of systolic and diastolic blood pressure, we corrected blood pressure measures in people on antihypertensive drugs by adding 15 mmHg to systolic and 10 mmHg to diastolic blood pressure, in keeping with the approach taken by genome-wide association studies 69 . Similar to the LD-Hub web resource 31 , we used linear regression analyses with sex and the first 10 principal components as covariates. For linear regression, we used the bgenie tool 59 . We removed participants from the accelerometer discovery sample (n=91,112), those who selfreported as being non-white British (n=68,428), had abnormal genetic versus self-reported sex mismatches (n=192) or sex chromosome aneuploidy (n=652). We also removed 48,658
participants due to relatedness. This left 278,367 UK Biobank participants who were not included in our discovery analysis, and other publicly available GWAS summary data from the MR-Base web platform 34 . Where possible, estimates were meta-analysed using a fixed effects model (inverse variance weighted average).
For analysis we retained index SNPs with p<5x10 -8 that were pruned for LD (r 2 < 0.001) and more than 10,000 kb apart. We then followed a number of steps to denote potential causality with disease outcomes (Note S2). We used the maximum likelihood-based approach as our primary source of MR estimates. This is based on published simulation results suggesting that causal estimates obtained from summarized data using a likelihood-based model are almost as precise as those obtained from individual-level data 36 . Only likelihood-based risk estimates that were significant after correction using a false-discovery rate of <5% were considered. The potential effect of pleiotropy was evaluated by three complementary approaches, namely weighted median and weighted mode estimation 70, 71 , and the regression intercept from the MR-Egger method 72 . The sensitivity of causal inference to any individual genetic variant was tested by leave-one-out analysis. The Steiger test was used to provide evidence for the causal direction of the effect estimates 73 . Additionally, for MR associations that appeared robust to sensitivity and pleiotropy analyses, bidirectional MR was conducted to assess the direction of the causal estimate. All MR analyses were conducted in R using the TwoSampleMR package 34 .
Investigating functional and biological mechanisms for activity and sleep traits
To investigate potential biological mechanisms underlying physical activity and sleep, we used DEPICT 38 To then identify pathways implicated by the activity and sleep associated loci, we used FUMA to perform hypergeometric tests on genes from these loci to investigate overrepresentations in genes predefined from the GWAS-catalog.
Data and code availability
The summary phenotype variables that we have constructed will be made available as a part Figure 1 | Miami plot of European sex-combined GWAS of physical activity in UK Biobank measured by accelerometer (top, n=91,112) and self-report (below, n=351,154).
Genomic control(λ), explained variance (R 2 ) and heritability (h 2 ) estimates are also provided.
Overall activity (n=91k): λ = 1.20, LD intercept = 1.01, h 2 = 0.21, R 2 (GWS loci) = 0.05%, R 2 (5x10 -3 loci) = 12.1%
Self-reported activity (n=351k): λ = 1.05, LD intercept = 1.01, h 2 = 0.06, R 2 (GWS loci) = nan%, R 2 (5x10 -3 loci) = 0.8% Figure 2 | Heritability partitioning enrichment estimates across functional categories and tissues, for median value across 5 physical activity and sleep traits. Annotated categories indicate tissues that pass the multiple testing significance threshold (p<9.44x10 -4 ).
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